The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Neurobehavioral Effects of Interferon-α in Cancer Patients Phenomenology and Paroxetine Responsiveness of Symptom Dimensions
Abstract
We have previously shown that the risk of major depression in patients with malignant melanoma undergoing interferon-alpha (IFN-alpha) therapy can be reduced by pretreatment with the antidepressant, paroxetine. Using dimensional analyses, the present study assessed the expression and treatment responsiveness of specific clusters of neuropsychiatric symptoms over the first three months of IFN-alpha therapy. Forty patients with malignant melanoma eligible for IFN-alpha treatment were randomly assigned to receive either paroxetine or placebo in a double-blind design. Neuropsychiatric assessments were conducted at regular intervals during the first twelve weeks of IFN-alpha therapy and included the 21-item Hamilton Depression Rating Scale, the 14-item Hamilton Anxiety Rating Scale and the Neurotoxicity Rating Scale. Neurovegetative and somatic symptoms including anorexia, fatigue and pain appeared within two weeks of IFN-alpha therapy in a large proportion of patients. In contrast, symptoms of depressed mood, anxiety and cognitive dysfunction appeared later during IFN-alpha treatment and more specifically in patients who met DSM-IV criteria for major depression. Symptoms of depression, anxiety, cognitive dysfunction and pain were more responsive, whereas symptoms of fatigue and anorexia were less responsive, to paroxetine treatment. These data demonstrate distinct phenomenology and treatment responsiveness of symptom dimensions induced by IFN-alpha, and suggest that different mec…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Exposure to pro-inflammatory cytokines produces a sickness syndrome with symptoms that overlap considerably with those seen in depression and that can be ameliorated by treatment with antidepressants23.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [23]
In the citing paper
“Administration of inflammatory cytokines (for example, IFNα) or their inducers (for example, endotoxin or typhoid vaccination) to otherwise non-depressed individuals causes symptoms of depression23–26.”
From The role of inflammation in depression: from evolutionary imperative to modern treatment target (2016) · cites this paper as [23]
In the citing paper
“Pre-treatment with paroxetine, a serotonin-reuptake inhibitor, reduces the psychological symptoms but has little or no effect on the concomitant neurovegetative symptomatology48.”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [48]
In the citing paper
“IFN-α causes marked depressive symptoms in a high percentage of patients, depending on the dose and route of administration.”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [97]
In the citing paper
“Prominent symptoms include depressed mood, anhedonia, fatigue, psychomotor slowing, anxiety, and insomnia.97”
From Cytokines and Glucocorticoid Receptor Signaling (2009) · cites this paper as [97]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282 · cited 1×
“American Psychiatric Association 1994 ), a Minimental State Exam l 24 (”
BackgroundHamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“Assessments At each evaluation, patients were administered a battery of observer-rated and self-report psychiatric assessments including the 21-item observer-rated Hamilton Rating Scale for Depression (HAM-D) (”
MethodDiagnostic and Statistical Manual of Mental Disorders
Raber, G., & Spokas, M. (2025) · The Sage Encyclopedia of Mood and Anxiety Disorders · doi:10.4135/9781071886229.n145 · Cited by 2,764
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Kirkwood, J. M., Strawderman, M. H., Ernstoff, M. S., Smith, T. J., Borden, E. C., & Blum, R. H. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.7 · Cited by 2,094
Ostwald, P. F. (1960) · American Journal of Psychotherapy · doi:10.1176/appi.psychotherapy.1960.14.4.817 · Cited by 1,357
Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment
Pariante, C. M., & Miller, A. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01088-x · Cited by 1,147 · cited 1×
“1995 ), and antidepressants have been shown to facilitate inhibitory feedback on cytokine secretion by endogenous glucocorticoids (”
BackgroundSelf-citationParoxetine for the prevention of depression induced by high-dose interferon alfa.
Musselman, D. L., Lawson, D. H., Gumnick, J. F., Manatunga, A. K., Penna, S., Goodkin, R. S., Greiner, K., Nemeroff, C. B., & Miller, A. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103293441303 · Cited by 1,120
Maier, W., Buller, R., Philipp, M., & Heuser, I. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90072-9 · Cited by 1,044 · cited 1×
“Hamilton 1960 ), the 14-item observer-rated Hamilton Anxiety Scale (HAM-A) (”
MethodPathogenesis, Natural History, Treatment, and Prevention of Hepatitis C
Liang, T. J., Rehermann, B., Seeff, L. B., & Hoofnagle, J. H. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00008 · Cited by 868
Cited by
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
From inflammation to sickness and depression: when the immune system subjugates the brain
Dantzer, R., O'Connor, J. C., Freund, G. G., Johnson, R. W., & Kelley, K. W. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2297 · Cited by 7,395
The role of inflammation in depression: from evolutionary imperative to modern treatment target
Miller, A. H., & Raison, C. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2015.5 · Cited by 3,942
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
Self-citation
Metadata
- Authors
- Capuron, L.
- Affiliations
- Emory University (US)
- Corresponding author
- Capuron, L
- ORCID
- Capuron, L
- Venue
- Neuropsychopharmacology
- Published
- 2002-05
- Volume
- 26
- Issue
- 5
- Pages
- 643-652
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W1969065116
- Cited by
- 797
- References
- 47
- Citations by year
- 2026: 12 · 2025: 24 · 2024: 22 · 2023: 30 · 2022: 28 · 2021: 63 · 2020: 31 · 2019: 31 · 2018: 48 · 2017: 26 · 2016: 48 · 2015: 40 · 2014: 20 · 2013: 46 · 2012: 51
- FWCI
- 10.25
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Funders
- National Institute of Mental Health (MH-00680, MH 60723, R01MH060723)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Keywords
- interferon-alpha, paroxetine, melanoma, major depressive disorder, neuropsychiatric symptoms, sickness behavior, cognitive impairment, anxiety, fatigue, anorexia, pain, antidepressant response, symptom phenomenology
- MeSH terms
- Adult, Aged, Analysis of Variance, Antineoplastic Agents, Double-Blind Method, Female, Humans, Male, Melanoma, Middle Aged, Neoplasms, Patients, Chi-Square Distribution, Interferon-alpha, Paroxetine, Antidepressive Agents, Second-Generation, Statistics, Nonparametric, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neurobehavioral Effects of Interferon-α in Cancer Patients Phenomenology and Paroxetine Responsiveness of Symptom Dimensions. https://app.cochat.ai/papers/10.1016/s0893-133x(01)00407-9
- The paper
- Capuron, L. (2002). Neurobehavioral Effects of Interferon-α in Cancer Patients Phenomenology and Paroxetine Responsiveness of Symptom Dimensions. Neuropsychopharmacology. https://doi.org/10.1016/s0893-133x(01)00407-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.